These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 2531546)

  • 1. Prenatal screening for Down syndrome with maternal serum human chorionic gonadotropin levels.
    Petrocik E; Wassman ER; Kelly JC
    Am J Obstet Gynecol; 1989 Nov; 161(5):1168-73. PubMed ID: 2531546
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated maternal midtrimester serum free beta-human chorionic gonadotropin levels in vegetarian pregnancies that cause increased false-positive Down syndrome screening results.
    Cheng PJ; Chu DC; Chueh HY; See LC; Chang HC; Weng DR
    Am J Obstet Gynecol; 2004 Feb; 190(2):442-7. PubMed ID: 14981387
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dimeric inhibin A as a marker for Down's syndrome in early pregnancy.
    Aitken DA; Wallace EM; Crossley JA; Swanston IA; van Pareren Y; van Maarle M; Groome NP; Macri JN; Connor JM
    N Engl J Med; 1996 May; 334(19):1231-6. PubMed ID: 8606718
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alpha-fetoprotein, free beta-human chorionic gonadotropin, and dimeric inhibin A produce the best results in a three-analyte, multiple-marker screening test for fetal Down syndrome.
    Wenstrom KD; Owen J; Chu DC; Boots L
    Am J Obstet Gynecol; 1997 Nov; 177(5):987-91. PubMed ID: 9396880
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated maternal urine level of beta-core fragment of human chorionic gonadotropin versus serum triple test in the second-trimester detection of down syndrome.
    Bahado-Singh R; Oz U; Rinne K; Hunter D; Cole L; Mahoney MJ; Baumgarten A
    Am J Obstet Gynecol; 1999 Oct; 181(4):929-33. PubMed ID: 10521756
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Triple marker (alpha-fetoprotein, unconjugated estriol, human chorionic gonadotropin) versus alpha-fetoprotein plus free-beta subunit in second-trimester maternal serum screening for fetal Down syndrome: a prospective comparison study.
    Kellner LH; Weiner Z; Weiss RR; Neuer M; Martin GM; Mueenuddin M; Bombard A
    Am J Obstet Gynecol; 1995 Oct; 173(4):1306-9. PubMed ID: 7485343
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Maternal serum Down syndrome screening: free beta-protein is a more effective marker than human chorionic gonadotropin.
    Macri JN; Kasturi RV; Krantz DA; Cook EJ; Moore ND; Young JA; Romero K; Larsen JW
    Am J Obstet Gynecol; 1990 Oct; 163(4 Pt 1):1248-53. PubMed ID: 1699417
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of urinary hyperglycosylated human chorionic gonadotropin concentration with the serum triple screen for Down syndrome detection in high-risk pregnancies.
    Bahado-Singh RO; Oz U; Shahabi S; Mahoney MJ; Baumgarten A; Cole LA
    Am J Obstet Gynecol; 2000 Nov; 183(5):1114-8. PubMed ID: 11084551
    [TBL] [Abstract][Full Text] [Related]  

  • 9. First-trimester Down syndrome screening: free beta-human chorionic gonadotropin and pregnancy-associated plasma protein A.
    Krantz DA; Larsen JW; Buchanan PD; Macri JN
    Am J Obstet Gynecol; 1996 Feb; 174(2):612-6. PubMed ID: 8623793
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Second trimester maternal serum pregnancy specific beta-1 glycoprotein (SP-1) levels in normal and Down syndrome pregnancies.
    Petrocik E; Wassman ER; Lee JJ; Kelly JC
    Am J Med Genet; 1990 Sep; 37(1):114-8. PubMed ID: 2146876
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Maternal serum screening for alpha-fetoprotein, unconjugated estriol, and human chorionic gonadotropin between 11 and 15 weeks of pregnancy to detect fetal chromosome abnormalities.
    Crandall BF; Hanson FW; Keener S; Matsumoto M; Miller W
    Am J Obstet Gynecol; 1993 Jun; 168(6 Pt 1):1864-7; discussion 1867-9. PubMed ID: 7686337
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospective evaluation of maternal serum human chorionic gonadotropin levels in 3428 pregnancies.
    Bogart MH; Jones OW; Felder RA; Best RG; Bradley L; Butts W; Crandall B; MacMahon W; Wians FH; Loeh PV
    Am J Obstet Gynecol; 1991 Sep; 165(3):663-7. PubMed ID: 1716420
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prenatal maternal dried blood screening with alpha-fetoprotein and free beta-human chorionic gonadotropin for open neural tube defect and Down syndrome.
    Macri JN; Anderson RW; Krantz DA; Larsen JW; Buchanan PD
    Am J Obstet Gynecol; 1996 Feb; 174(2):566-72. PubMed ID: 8623786
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Maternal serum hyperglycosylated human chorionic gonadotrophin (HhCG) in the first trimester of pregnancies affected by Down syndrome, using a sialic acid-specific lectin immunoassay.
    Spencer K; Talbot JA; Abushoufa RA
    Prenat Diagn; 2002 Aug; 22(8):656-62. PubMed ID: 12210572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of maternal serum hCG glycoform variants in the second trimester of pregnancies affected by Down syndrome using a lectin immunoassay.
    Talbot JA; Spencer K; Abushoufa RA
    Prenat Diagn; 2003 Jan; 23(1):1-5. PubMed ID: 12533803
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential prenatal predictions of Down syndrome: a statistical analysis.
    O'Brien WF; Knuppel RA; Torres C; Sternlicht D
    Am J Obstet Gynecol; 1990 Dec; 163(6 Pt 1):1796-8. PubMed ID: 1701614
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A prospective trial of prenatal screening for Down syndrome by means of maternal serum alpha-fetoprotein, human chorionic gonadotropin, and unconjugated estriol.
    Burton BK; Prins GS; Verp MS
    Am J Obstet Gynecol; 1993 Sep; 169(3):526-30. PubMed ID: 7690522
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A screening program for trisomy 21 at 10-14 weeks using fetal nuchal translucency, maternal serum free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A.
    Spencer K; Souter V; Tul N; Snijders R; Nicolaides KH
    Ultrasound Obstet Gynecol; 1999 Apr; 13(4):231-7. PubMed ID: 10341399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectiveness of combining maternal serum alpha-fetoprotein and hCG in a second-trimester screening program for Down syndrome.
    Mooney RA; Peterson CJ; French CA; Saller DN; Arvan DA
    Obstet Gynecol; 1994 Aug; 84(2):298-303. PubMed ID: 7518896
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated second-trimester dimeric inhibin A levels identify Down syndrome pregnancies.
    Wenstrom KD; Owen J; Chu DC; Boots L
    Am J Obstet Gynecol; 1997 Nov; 177(5):992-6. PubMed ID: 9396881
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.